Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/sctm.17-0196 http://scihub22266oqcxt.onion/10.1002/sctm.17-0196 C5866934!5866934 !29468830     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=29468830 &cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Stem+Cells+Transl+Med 2018 ; 7 (4 ): 354-359 Nephropedia Template TP {{tp|p=29468830 |t=2018. Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future |pdf=|usr=}}{{29468830 }} gab.com Text Concise Review: Is Cardiac Cell Therapy Dead Embarrassing Trial Outcomes and New Directions for the Future JO: Stem Cells Transl Med http://www.kidney.de/pget.php?&tw=1&pmid=29468830 #FOAvip Stem cell therapy is a promising strategy for tissue regeneration. The therapeutic benefits of cell therapy are mediated by both direct and indirect mechanisms. However, the application of stem cell therapy in the clinic is hampered by several limitations. This concise review provides a brief introduction into stem cell therapies for ischemic heart disease. It summarizes cell-based and cell-free paradigms, their limitations, and the benefits of using them to target disease. Stem Cells Translational Medicine 2018;7:354-359. Twit Text FOAVip Concise Review: Is Cardiac Cell Therapy Dead Embarrassing Trial Outcomes and New Directions for the Future ????Stem Cells Transl Med http://www.kidney.de/pget.php?&tw=1&pmid=29468830 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=29468830 #FOAvip English Wikipedia <ref>{{Cite pmid|29468830 }}</ref> Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outcomes and New Directions for the Future #MMPMID29468830 Tang JN ; Cores J ; Huang K ; Cui XL ; Luo L ; Zhang JY ; Li TS ; Qian L ; Cheng K Stem Cells Transl Med 2018[Apr]; 7 (4 ): 354-359 PMID29468830 show ga Stem cell therapy is a promising strategy for tissue regeneration. The therapeutic benefits of cell therapy are mediated by both direct and indirect mechanisms. However, the application of stem cell therapy in the clinic is hampered by several limitations. This concise review provides a brief introduction into stem cell therapies for ischemic heart disease. It summarizes cell-based and cell-free paradigms, their limitations, and the benefits of using them to target disease. Stem Cells Translational Medicine 2018;7:354-359. |Animals [MESH] |Cell- and Tissue-Based Therapy/*methods [MESH] |Heart Diseases/therapy [MESH] |Heart/*physiology [MESH] |Humans [MESH] |Regeneration/physiology [MESH] |Stem Cell Transplantation/methods [MESH]Concise Review: Is Cardiac Cell Therapy Dead? Embarrassing Trial Outco(epmc).pdf DeepDyve Pubget Overpricing